The World Health Organization (WHO) has recommended the use of a malaria vaccine developed at Oxford University in the UK, after concluding it is 75% effective at protecti
Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing for their COVID-19 vaccine, based on a conventional recombinant p